Anaemia management with C.E.R.A. in routine clinical practice: OCEANE (Cohorte Mircera patients non-dialysés), a national, multicenter, longitudinal, observational prospective study, in patients with chronic kidney disease not on dialysis

OBJECTIVE: The aim of this study was to describe the management of anaemia with a continuous erythropoietin receptor activator (C.E.R.A., methoxy polyethylene glycol epoetin-β), in patients with chronic kidney disease (CKD) not on dialysis, naïve or non-naïve to treatment with erythropoiesis-stimula...

Descripción completa

Detalles Bibliográficos
Autores principales: Frimat, Luc, Mariat, Christophe, Landais, Paul, Koné, Sébastien, Commenges, Bénédicte, Choukroun, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612788/
https://www.ncbi.nlm.nih.gov/pubmed/23474787
http://dx.doi.org/10.1136/bmjopen-2012-001888

Ejemplares similares

Ejemplares similares